Skip to main content
. Author manuscript; available in PMC: 2024 Dec 9.
Published in final edited form as: Nat Immunol. 2024 Apr 12;25(5):764–777. doi: 10.1038/s41590-024-01817-w

Extended Data Figure 8: Normal T cell phenotyping results in the SHARPIN-deficient patient ex vivo.

Extended Data Figure 8:

(a) T cell proliferation assay. PMBCs were incubated with Cell Trace Violet, stimulated with anti-CD3/28 or PHA for 72h and analyzed by flow cytometer. (b) Intracellular cytokine staining for Th1, Th2 and Th17 populations. PBMCs were stimulated with PMA (100 ng/ml) and ionomycin (1 μM) for 5h with Brefeldin A. Stimulated cells were surface stained, fixed and permeabilized with BD Cytofix/Cytoperm kit. Cells were further stained for intracellular cytokines and analyzed by flow cytometry. Ctrl: unrelated healthy control, Sister: sister carrying the heterozygous frameshift SHARPIN variant p.Leu74ProfsX86. Representative result of two independent experiments.